“…When stimulated with the agonistic lipid α-galactosylceramide (αGalCer), they rapidly secrete high amounts of several cytokines, and there is growing interest in exploiting αGalCer as an immunological adjuvant (Carreno et al, 2014; Singh et al, 2014; Venkataswamy et al, 2014). iNKT cells also secrete cytokines at steady state and early after infection to influence the development and activation of surrounding immune cells (Engel and Kronenberg, 2014; Lee et al, 2013). Despite being essentially monospecific, iNKT cells nonetheless display substantial functional heterogeneity, with subsets producing different cytokines having distinct tissue localization preferences (Coquet et al, 2008; Doisne et al, 2009; Doisne et al, 2011; Michel et al, 2007; Terashima et al, 2008; Watarai et al, 2012).…”